Integrating multi-omics data and machine learning to identify endocrine disrupting chemicals targeting key

Mengzhuo Zheng1, Debiao Wang2, Bo Guan3

  • 1College of Informatics, Huazhong Agricultural University, Wuhan, 430070, China.

Discover Oncology
|December 30, 2025
PubMed

Insights

This study identifies 8 endocrine-disrupting chemicals (EDCs) and 5 key genes linked to clear cell renal cell carcinoma (ccRCC) progression. Findings reveal EDC-gene interactions influencing the tumor microenvironment, aiding ccRCC treatment strategies.

Area of Science:

  • Oncology
  • Environmental Health
  • Genomics

Background:

  • Clear cell renal cell carcinoma (ccRCC) is an aggressive cancer with poorly understood genetic and environmental risk factors.
  • The specific roles of endocrine-disrupting chemicals (EDCs) in ccRCC development and progression are not well-defined.

Purpose of the Study:

  • To identify EDCs and their associated genes involved in ccRCC pathogenesis using multi-omics and machine learning.
  • To elucidate the mechanisms by which EDCs influence ccRCC through gene expression and tumor microenvironment interactions.

Main Methods:

  • Integration of multi-omics datasets, including bulk and single-cell RNA sequencing.
  • Application and evaluation of 101 machine learning algorithms to build a prognostic model for ccRCC.
  • Pathway enrichment, immune infiltration, and cell-cell communication analyses.

Main Results:

  • Identification of 8 potential EDCs (e.g., Diethylnitrosamine, Arsenic, Lead) implicated in ccRCC.
  • Discovery of 5 prognostic genes (BIRC5, CCND1, RRM2, CDH1, TRIB3) associated with EDC exposure.
  • Characterization of gene-environment interactions within the tumor microenvironment and distinct cellular signaling patterns.

Conclusions:

  • This research highlights specific EDCs and genes as critical players in ccRCC pathogenesis.
  • The findings offer novel insights into EDC-driven tumor biology and ccRCC progression.
  • This study lays the groundwork for developing targeted therapies and preventative strategies for ccRCC.